R Li, X Wu, K Xue, D Feng, J Li, J Li - Biomarker Research, 2023 - Springer
Abstract Background Although t (8; 21) is in fact considered a good risk acute myeloid
leukemia (AML), only 60% of the patients live beyond 5 years after diagnosis. Studies have …